Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
Asthma/Airway Disease Rsch Ctr
40 active people
34 grants
Recent Grants
A Role for Pharmaceutical Control of Protease-activated Receptor-2 for the Treatment of Asthma
2024
·
$716.7K
asthma,
treatment,
protease inhibition
Breathing Easier in Schools: Enhancing Adoption, Fidelity, and Effectiveness of the SAFE School Program through Innovation Implementation Strategies (School in place of Albuterol)
2024
·
$714.6K
health,
education,
implementation,
innovation,
effectiveness
Defining Mechanisms Of Cc16 On Epithelial-driven Host Responses To Pathogens
2024
·
$606.4K
immune system,
lung disease,
host-pathogen interactions,
protein biology,
infectious diseases
Empowering Communities: Amplifying the Reach of the Stock Inhaler for Schools Program in Rural Counties and Tribal Nations through Strategic Partnerships
2024
·
$380K
community health,
collaborative partnerships,
rural health,
school health,
tribal health
Pharmacokinetic and Efficacy Studies of the Aerosolized PAR2 Antagonist, C781, for the Treatment of Asthma
2024
·
$251.8K
pharmacokinetics,
asthma treatment,
efficacy
Creatine Kinase in the Natural History of Asthma
2024
·
$231.6K
asthma,
natural history,
biomarkers,
inflammation
Therapeutics Development Center Award
2024
·
$150.5K
therapeutics,
drug development,
medical research,
healthcare innovation,
funding opportunities
A Research Study to Advance the CF Therapeutics Pipeline for People without Modulators
2024
·
$77K
cystic fibrosis,
therapeutics,
clinical research,
pipeline,
modulators
A Multicentre, Randomised, Double-blind, Parallel Group,Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eos
2023
·
$2.9M
asthma,
pediatric patients,
clinical trial,
drug treatment
CFF Data and Safety Monitoring Board
2023
·
$1.1M
clinical trials,
data monitoring,
safety,
healthcare regulation,
medical ethics
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Study to Assess the Efficacy and Safety of Daily OM-85 Treatment Versus Placebo Given on Top of Standard of Care in Children Aged
2023
·
$814.9K
clinical trial,
immunotherapy,
pediatric medicine,
respiratory health,
drug efficacy
A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous lmmunotherapy with DBV712 250 ?g in 4-7-year-old Children with Peanut Allergy (VITESSE)
2023
·
$397.9K
immunotherapy,
peanut allergy,
efficacy,
safety,
children
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)
2023
·
$292K
nutrition,
lung function,
muscle strength,
cystic fibrosis,
outcomes
A Randomised, Double-blind, Parallel Group Phase III Study To Assess The Efficacy And Safety Of 100 Mg Sc Depemokimab In Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Anchor 2 Depem
2023
·
$203.2K
chronic rhinosinusitis,
nasal polyps,
efficacy,
safety
Development of Small Molecule Antagonists of PAR2 for Oral Treatment of Asthma
2023
·
$154.4K
drug development,
asthma treatment,
oral administration,
small molecules
A Phase I Clinical Trial to Evaluate the Safety and Tolerability of VLP Peanut in Healthy Subjects and Subjects With Peanut Allergy and to Explore Preliminary Signals of Its Efficacy (PROTECT)
2023
·
$137.8K
clinical trials,
peanut allergy,
vaccine,
safety,
efficacy
Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes (STOP360)
2023
·
$125.2K
pulmonary exacerbations,
treatment standardization,
evaluation platform,
treatment decisions,
outcomes improvement
Food Allergy patient Samples (OATS)
2023
·
$61.1K
food allergy,
patient samples,
oats,
medical research,
immunology
Innovations for Home Spirometry Implementation in Youth with Cystic Fibrosis (I-SPY)
2023
·
$38.1K
innovations,
youth,
cystic fibrosis,
implementation
Development of SP-A-Derived Peptidomimetics for the Treatment of Asthma - Phase II
2022
·
$1M
peptidomimetics,
asthma,
sp-a-derived,
treatment,
development
People
Avery DeVries
Researcher/Scientist III
Ashley Michael
Research Technologist II
Amber Spangenberg
Research Specialist, Principal
Elizabeth Firmage
Administrative Operations Manager IV
Elvira Begay
Research Professional I
Buffy Tso
Research Professional I
Bruce Saul
Database Administrator II
Melissa Campos
Clinical Research Coordinator I
Clara Ehrman
Research Program Administration Officer I
Craig Weber
Research Manager II
Debra Stern
Data Scientist Manager III
Dayna Anderson
Research Technologist II
Destiny Hessel
Research Technician II
David Spies
Applications Systems Analyst/Developer, Senior
Elia Cornidez
Clinical Research Coordinator III
Elizabeth Ryan
Clinical Research Coordinator IV
Erin Cool
Accounting Manager I
Eva Barrow
Administrative Support Assistant II
Emily Waldron
Community Outreach Professional III
Gabriel Camacho
Clinical Research Coordinator IV
Glenda Jerezano
Administrative Support Professional I
Hyunjin Kang
Research Professional II
Jaesa Strong
Research Compliance Administrator III
Janell Merchen
Nurse Practitioner III
Leslie Hargrove
Research Program Administration Officer III
Misti Romig
Clinical Research Coordinator I
Meg Rother-Gossmann
Administrative Support Professional II
Michele Simon
Grant and Contract Administrator II
Megan Peterson
Research Nurse II
Nathan Mottern
Community Outreach Professional I
Nipasiri Trudeau
Researcher/Scientist III
Nirushan Narendran
Clinical Research Coordinator III
Osmara Molina de Rodriguez
Clinical Research Manager II
Oksana Pivniouk
Research Laboratory Manager I
Sheilah Allison
Research Technician III
Sasipa Tanyaratsrisakul
Researcher/Scientist III
Seongmin Hahn
Research Technologist II
Silvia Lopez
Research Nurse III
Sunil Banskar
Researcher/Scientist III
Zachary Stetson
App Develop Prgmer Analyst I
